A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

December 13, 2016

Primary Completion Date

December 29, 2021

Study Completion Date

December 29, 2021

Conditions
Chronic Lymphocytic Leukemia (CLL)
Interventions
DRUG

Venetoclax

Venetoclax tablets were to be taken orally once daily with a meal and water in the morning at approximately the same time each day. Tablets were to be swallowed whole and not chewed, crushed, or broken prior to swallowing.

Trial Locations (33)

100

National Taiwan University Hospital /ID# 150838, Taipei

1085

Semmelweis Egyetem /ID# 150792, Budapest

1097

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 152842, Budapest

1114

Fundaleu /Id# 150811, Ciudad Autonoma de Buenos Aire

1431

Cemic /Id# 150810, Ciudad Autonoma de Buenos Aire

UMHAT Alexandrovska EAD /ID# 162987, Sofiya

UMHAT Sveti Ivan Rilski /ID# 163280, Sofia

1756

SHAT Hematologic Diseases /ID# 161592, Sofia

1902

Hospital Italiano La Plata /ID# 150812, La Plata

2025

Middlemore Clinical Trials /ID# 161526, Papatoetoe

2170

Liverpool Hospital /ID# 154950, Liverpool

2217

St George Hospital /ID# 154212, Kogarah

3000

Peter MacCallum Cancer Ctr /ID# 154948, Melbourne

4002

UMHAT Sveti Georgi /ID# 161594, Plovdiv

4215

Gold coast University Hospital /ID# 150833, Southport

5000

Sanatorio Allende /ID# 150813, Córdoba

6009

Perth Blood Institute Ltd /ID# 154949, Nedlands

6021

Wellington Regional Hospital /ID# 157627, Newtown

11217

Taipei Veterans General Hosp /ID# 153803, Taipei

40447

China Medical University Hospital /ID# 150839, Taichung

58260

Centro de Investigacion Clínica Chapultepec SA de CV /ID# 163641, Morelia

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 150821, Monterrey

115478

Federal State Budgetary Scientific Institution N.N. Blokhin /ID# 166610, Moscow

125167

Federal State Budgetary Ins NRC for Hematology of MoH of Russian Federation /ID# 154213, Moscow

125284

Moscow State budget healthcare /ID# 154806, Moscow

440071

Regional Oncological Dispensary /ID# 154202, Penza

999077

Prince of Wales Hospital /ID# 150837, Hong Kong

Queen Mary Hospital /ID# 150836, Hong Kong

0622

North Shore Hospital /ID# 157626, Takapuna

02-776

Instytut Hematologii i Transfuzjologii /ID# 150878, Warsaw

81-519

Szpitale Pomorskie Sp. z o.o /ID# 164097, Gdynia

41-500

SP ZOZ Zespol Szpitali Miejskich w Chorzowie /ID# 150877, Chorzów

93-513

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopern /ID# 150880, Lodz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY